Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
Mounzer Agha, Maggie Blake, Charles Chilleo, View ORCID ProfileAlan Wells, Ghady Haidar
doi: https://doi.org/10.1101/2021.04.06.21254949
Mounzer Agha
1Hillman Cancer Center, UPMC, Pittsburgh, PA, USA
Maggie Blake
1Hillman Cancer Center, UPMC, Pittsburgh, PA, USA
Charles Chilleo
3UPMC Clinical Laboratories, Pittsburgh, PA, USA
Alan Wells
2Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Ghady Haidar
4Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 07, 2021.
Suboptimal response to COVID-19 mRNA vaccines in hematologic malignancies patients
Mounzer Agha, Maggie Blake, Charles Chilleo, Alan Wells, Ghady Haidar
medRxiv 2021.04.06.21254949; doi: https://doi.org/10.1101/2021.04.06.21254949
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2599)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12134)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4028)
- Geriatric Medicine (379)
- Health Economics (670)
- Health Informatics (2605)
- Health Policy (994)
- Hematology (358)
- HIV/AIDS (831)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3797)
- Nursing (208)
- Nutrition (563)
- Oncology (1989)
- Ophthalmology (576)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (249)
- Palliative Medicine (72)
- Pathology (470)
- Pediatrics (1098)
- Primary Care Research (443)
- Public and Global Health (6469)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (51)
- Transplantation (185)
- Urology (165)